GlassScriptPhysician profile
Pandora Smith
NPI 1922623578
$1,515.07
in general payments reported to CMS, 2019-2025
17 companies · $122 in 2025
The $122 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,144 · 2022: $249 · 2025: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $122.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $195.45 | 2021 | |
| Eisai INC. | $158.09 | 2021 | |
| Avanos Medical | $154.40 | 2021 | |
| Boston Scientific Corporation | $128.69 | 2021 | |
| Acadia Pharmaceuticals INC | $122.17 | 2025 | Daybue |
| Bayer Healthcare Pharmaceuticals INC. | $122.07 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $118.25 | 2021 | |
| Abbott Laboratories | $108.42 | 2022 | |
| Nevro Corp. | $82.54 | 2021 | |
| Genentech USA, INC. | $71.38 | 2021 | |
| Grt US Holding, INC. | $60.82 | 2021 | |
| Arbor Pharmaceuticals, INC. | $52.97 | 2021 | |
| Novartis Pharmaceuticals Corporation | $43.37 | 2021 | |
| Pfizer INC. | $33.41 | 2021 | |
| Radius Health, INC. | $23.08 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $21.05 | 2021 | |
| Organon LLC | $18.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pandora Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.